Zofran and Seborrhea - a phase IV clinical study of FDA data

Summary:

Seborrhea is reported as a side effect among people who take Zofran (ondansetron hydrochloride), especially for people who are male, 40-49 old, also take Adderall, and have Foetal exposure during pregnancy.

The phase IV clinical study analyzes which people have Seborrhea when taking Zofran. It is created by eHealthMe based on reports of 93,713 people who have side effects when taking Zofran from the FDA, and is updated regularly.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Seborrhea?

Seborrhea is found to be associated with 218 drugs and 412 conditions by eHealthMe. Check the latest studies of Seborrhea.

On Jul, 13, 2026

93,713 people reported to have side effects when taking Zofran.
Among them, 24 people (0.03%) have Seborrhea.

Among these 24 people:

What is the gender of people who have Seborrhea when taking Zofran? *

female: 17.39 %
male: 82.61 %

What is the age of people who have Seborrhea when taking Zofran? *

What are other drugs people take besides Zofran? *

What are other side effects people have besides Seborrhea? *

Stress And Anxiety: 17 people, 70.83%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 13 people, 54.17%
Injury: 13 people, 54.17%
Pain: 10 people, 41.67%
Muscle Spasms (muscle contraction): 9 people, 37.50%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 9 people, 37.50%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 8 people, 33.33%
Upper Respiratory Tract Infection: 8 people, 33.33%
Feeling Abnormal: 8 people, 33.33%
Emotional Distress: 8 people, 33.33%

What are the existing conditions these people have? *

Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 13 people, 54.17%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 29.17%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 29.17%
Muscle Twitching: 6 people, 25.00%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.17%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and have Seborrhea?

- Check whether Seborrhea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zofran:

Zofran (94,987 reports)

Seborrhea treatments and more:

Seborrhea (5,552 reports)

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seborrhea:

Seborrhea (218 drugs)

Browse all the conditions that are associated with Seborrhea:

Seborrhea (412 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron hydrochloride (the active ingredients of Zofran) and Zofran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.